Richard B. Kim, MD, FRCPC, Division Chair
Dr. Kim received his medical degree from University of Saskatchewan, Canada in 1987. After completing an internship and residency training at the Royal University hospital in Saskatoon Canada in 1991, he went on to carry out postdoctoral fellowship training in Clinical Pharmacology at Vanderbilt University. In 1994, upon completion of his fellowship training, he remained at Vanderbilt Clinical Pharmacology and rose through the ranks to full Professor by 2004. July 2006, he and his group moved from Vanderbilt University to the Department of Medicine at the University of Western Ontario, to lead a program of Translational and Personalized Medicine research.
He is currently Professor and Chair of the Division of Clinical Pharmacology, Associate Chair for Research in the Department of Medicine at the University of Western Ontario. His research interest is that of understanding the molecular basis of interindividual differences in drug disposition and the application of such finding to the emerging field of Personalized Medicine. In 2008, Dr. Kimís group was the first in Canada to start a personalized medicine clinic and he is now moving forward with a comprehensive Personalized Medicine Program focused on individualization of drug therapy for cancer, vascular diseases, diabetes, children, and the elderly.
Dr. Kim received the Leon-Goldberg Young Investigator Award from the American Society for Clinical Pharmacology and Therapeutics in 2000, New Investigator Award from the International Society for the Study of Xenobiotics (ISSX) in 2002. In 2008, he received the inaugural Lawson Innovation Prize. In 2010 he was awarded Cancer Care Ontario Research Chair (Tier-1) in Experimental Therapeutics. In 2012, he was awarded the Wolfe Medical Research Chair in Pharmacogenomics from Schulich School of Medicine & Dentistry at Western. He is a Fellow of the American Society for Pharmaceutical Sciences (AAPS), and an elected Member of the American Society for Clinical Investigation (ASCI).